1.
Ambrosini A, Estemalik E, Pascual J, Rettiganti M, Stroud C, Day K, Ford J. Effects of galcanezumab on acute medication use and health care resource utilization in treatment-resistant migraine: results from randomized, double blind, placebo-controlled clinical trial, conquer. Headache Med [Internet]. 2020 Nov. 30 [cited 2024 Nov. 21];11(Supplement):27. Available from: https://headachemedicine.com.br/index.php/hm/article/view/112